INVICTUS: Intravitreal anti-VEGF and dexamethasone implant comparison for the treatment of diabetic macular edema: A 12 months follow-up study.
Alban CometPierre GasconPrithvi RamtohulBenjamin DonnadieuDanièle DenisFrédéric MatontiPublished in: European journal of ophthalmology (2020)
In summary, these three drugs provide an efficient treatment option with an acceptable benefit-risk ratio for the treatment of naive patients with DME, whether on BCVA or CRT on the first year of treatment.